|
1
|
Stühmer W, Alves F, Hartung F, Zientkowska
M and Pardo LA: Potassium channels as tumour markers. FEBS Lett.
580:2850–2852. 2006.PubMed/NCBI
|
|
2
|
Lastraioli E, Taddei A, Messerini L, et
al: hERG1 channels in human esophagus: evidence for their aberrant
expression in the malignant progression of Barrett’s esophagus. J
Cell Physiol. 209:398–404. 2006.PubMed/NCBI
|
|
3
|
Masi A, Becchetti A, Restano-Cassulini R,
et al: hERG1 channels are overexpressed in glioblastoma multiforme
and modulate VEGF secretion in glioblastoma cell lines. Br J
Cancer. 93:781–792. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Panner A and Wurster RD: T-type calcium
channels and tumor proliferation. Cell Calcium. 40:253–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diss JK, Stewart D, Pani F, et al: A
potential novel marker for human prostate cancer: voltage-gated
sodium channel expression in vivo. Prostate Cancer Prostatic Dis.
8:266–273. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fraser SP, Diss JK, Chioni AM, et al:
Voltage-gated sodium channel expression and potentiation of human
breast cancer metastasis. Clin Cancer Res. 11:5381–5389. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Furst J, Gschwentner M, Ritter M, et al:
Molecular and functional aspects of anionic channels activated
during regulatory volume decrease in mammalian cells. Pflugers
Arch. 444:1–25. 2002.PubMed/NCBI
|
|
8
|
Ferrera L, Caputo A and Galietta LJ:
TMEM16A protein: a new identity for Ca(2+)-dependent Cl-
channels. Physiology (Bethesda). 25:357–363. 2010.
|
|
9
|
Hartzell C, Putzier I and Arreola J:
Calcium-activated chloride channels. Annu Rev Physiol. 67:719–758.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caputo A, Caci E, Ferrera L, et al:
TMEM16A, a membrane protein associated with calcium-dependent
chloride channel activity. Science. 322:590–594. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang YD, Cho H, Koo JY, et al: TMEM16A
confers receptor-activated calcium-dependent chloride conductance.
Nature. 455:1210–1215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schroeder BC, Cheng T, Jan YN and Jan LY:
Expression cloning of TMEM16A as a calcium-activated chloride
channel subunit. Cell. 134:1019–1029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rock JR, O’Neal WK, Gabriel SE, et al:
Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated
Cl− secretory channel in mouse airways. J Biol Chem.
284:14875–14880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang F, Rock JR, Harfe BD, et al: Studies
on expression and function of the TMEM16A calcium-activated
chloride channel. Proc Natl Acad Sci USA. 106:21413–21418. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang SJ, Blair PJ, Britton FC, et al:
Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is
fundamental for slow wave activity in gastrointestinal muscles. J
Physiol. 587:4887–4904. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romanenko VG, Catalán MA, Brown DA, et al:
Tmem16A encodes the Ca2+-activated Cl−
channel in mouse submandibular salivary gland acinar cells. J Biol
Chem. 285:12990–13001. 2010.PubMed/NCBI
|
|
17
|
Elble RC and Pauli BU: Tumor suppression
by a proapoptotic calcium-activated chloride channel in mammary
epithelium. J Biol Chem. 276:40510–40517. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spitzner M, Martins JR, Soria RB, et al:
Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic
cancer cells. J Biol Chem. 283:7421–7428. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katoh M and Katoh M: FLJ10261 gene,
located within the CCND1-EMS1 locus on human chromosome 11q13,
encodes the eight-transmembrane protein homologous to C12orf3,
C11orf25 and FLJ34272 gene products. Int J Oncol. 22:1375–1381.
2003.PubMed/NCBI
|
|
20
|
Akervall JA, Jin Y, Wennerberg JP, et al:
Chromosomal abnormalities involving 11q13 are associated with poor
prognosis in patients with squamous cell carcinoma of the head and
neck. Cancer. 76:853–859. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwab M: Amplification of oncogenes in
human cancer cells. Bioessays. 20:473–479. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carles A, Millon R, Cromer A, et al: Head
and neck squamous cell carcinoma transcriptome analysis by
comprehensive validated differential display. Oncogene.
25:1821–1831. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Espinosa I, Lee CH, Kim MK, et al: A novel
monoclonal antibody against DOG1 is a sensitive and specific marker
for gastrointestinal stromal tumors. Am J Surg Pathol. 32:210–218.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kashyap MK, Marimuthu A, Kishore CJ, et
al: Genomewide mRNA profiling of esophageal squamous cell carcinoma
for identification of cancer biomarkers. Cancer Biol Ther. 8:36–46.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang H, Huang LY, Zeng DY, et al: Decrease
of intracellular chloride concentration promotes endothelial cell
inflammation by activating nuclear factor-kappaB pathway.
Hypertension. 60:1287–1293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen J, Fok KL, Chen H, et al:
Cryptorchidism-induced CFTR down-regulation results in disruption
of testicular tight junctions through up-regulation of
NF-κB/COX-2/PGE2. Hum Reprod. 27:2585–2597. 2012.PubMed/NCBI
|
|
27
|
He G, Ma Y, Chou SY, et al: Role of CLIC4
in the host innate responses to bacterial lipopolysaccharide. Eur J
Immunol. 41:1221–1230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sheridan GK, Pickering M, Twomey C, et al:
NF-kappaB activity in distinct neural subtypes of the rat
hippocampus: Influence of time and GABA antagonism in acute slice
preparations. Learn Mem. 14:525–532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miller FJ Jr, Filali M, Huss GJ, et al:
Cytokine activation of nuclear factor kappa B in vascular smooth
muscle cells requires signaling endosomes containing Nox1 and
ClC-3. Circ Res. 101:663–671. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Laver T, Nozell S and Benveniste EN: The
NF-κB signaling pathway in GBMs: implications for apoptotic and
inflammatory responses and exploitation for therapy. CNS Cancer:
Models, Markers, Prognostic Factors, Targets and Therapeutic
Approaches. Van Meir EG: 1. Humana Press (Springer); New York, NY:
pp. 1011–1036. 2009
|
|
31
|
Gilmore TD: Introduction to NF-kappaB:
players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perkins ND: The Rel/NF-kappa B family:
friend and foe. Trends Biochem Sci. 25:434–440. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perkins ND and Gilmore TD: Good cop, bad
cop: the different faces of NF-kappaB. Cell Death Differ.
13:759–772. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
36
|
Lee CH, Jeon YT, Kim SH and Song YS:
NF-kappaB as a potential molecular target for cancer therapy.
Biofactors. 29:19–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sethi G, Sung B and Aggarwal BB: Nuclear
factor-kappaB activation: from bench to bedside. Experiment Biol
Med (Maywood). 233:21–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van Waes C: Nuclear factor-kappaB in
development, prevention, and therapy of cancer. Clin Cancer Res.
13:1076–1082. 2007.PubMed/NCBI
|
|
39
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
40
|
Veeravalli KK and Rao JS: MMP-9 and uPAR
regulated glioma cell migration. Cell Adh Migr. 6:509–512. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kesanakurti D, Chetty C, Rajasekhar
Maddirela D, Gujrati M and Rao JS: Functional cooperativity by
direct interaction between PAK4 and MMP-2 in the regulation of
anoikis resistance, migration and invasion in glioma. Cell Death
Dis. 3:e4452012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Habela CW, Ernest NJ, Swindall AF and
Sontheimer H: Chloride accumulation drives volume dynamics
underlying cell proliferation and migration. J Neurophysiol.
101:750–757. 2009.PubMed/NCBI
|
|
43
|
Habela CW, Olsen ML and Sontheimer H: ClC3
is a critical regulator of the cell cycle in normal and malignant
glial cells. J Neurosci. 28:9205–9217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kunzelmann K, Kongsuphol P, Aldehni F, et
al: Bestrophin and TMEM16-Ca(2+) activated Cl(−) channels with
different functions. Cell Calcium. 46:233–241. 2009.PubMed/NCBI
|
|
45
|
Ayoub C, Wasylyk C, Li Y, et al: ANO1
amplification and expression in HNSCC with a high propensity for
future distant metastasis and its functions in HNSCC cell lines. Br
J Cancer. 103:715–726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Duvvuri U, Shiwarski DJ, Xiao D, et al:
TMEM16A induces MAPK and contributes directly to tumorigenesis and
cancer progression. Cancer Res. 72:3270–3281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Simon S, Grabellus F, Ferrera L, et al:
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal
tumors. Cancer Res. 73:3661–3670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mazzone A, Eisenman ST, Strege PR, et al:
Inhibition of cell proliferation by a selective inhibitor of the
Ca(2+)-activated Cl(−) channel, Ano1. Biochem Biophys Res Commun.
427:248–253. 2012.
|
|
49
|
Liu W, Lu M, Liu B, Huang Y and Wang K:
Inhibition of Ca(2+)-activated Cl(−) channel ANO1/TMEM16A
expression suppresses tumor growth and invasiveness in human
prostate carcinoma. Cancer Lett. 326:41–51. 2012.
|
|
50
|
Abdullah JM, Ahmad F, Ahmad KA, et al:
Molecular genetic analysis of BAX and Cyclin D1 genes in patients
with malignant glioma. Neurol Res. 29:239–242. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Arato-Ohshima T and Sawa H:
Over-expression of cyclin D1 induces glioma invasion by increasing
matrix metalloproteinase activity and cell motility. Int J Cancer.
83:387–392. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang X, Zhao M, Huang AY, et al: The
effect of cyclin D expression on cell proliferation in human
gliomas. J Clin Neurosci. 12:166–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liao DJ, Thakur A, Wu J, Biliran H and
Sarkar FH: Perspectives on c-Myc, cyclin D1, and their interaction
in cancer formation, progression, and response to chemotherapy.
Crit Rev Oncogen. 13:93–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Robson S, Pelengaris S and Khan M: c-Myc
and downstream targets in the pathogenesis and treatment of cancer.
Recent Pat Anticancer Drug Discov. 1:305–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
